Home > Qtrly Results > CONCORD DRUGS

CONCORD DRUGS
Quarterly Results Analysis [Mar2026]

CONCORD DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹38 Cr ₹17 Cr ₹10 Cr ₹14 Cr ₹10 Cr ₹11 Cr ₹12 Cr ₹12 Cr
Expenses ₹36 Cr ₹16 Cr ₹9 Cr ₹13 Cr ₹9 Cr ₹9 Cr ₹11 Cr ₹11 Cr
Operating Income ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr
Profit After Tax ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
EPS ₹0.40 ₹0.16 ₹0.19 ₹0.12 ₹0.04 ₹0.23 ₹0.04 ₹0.03
Industry Peers & Returns1W1M1Y
CONCORD DRUGS -1% -6.7% 144.4%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 1.2% 13.8%
DIVIS LABORATORIES -0.5% -0.6% 4%
TORRENT PHARMACEUTICALS 2.1% 1.5% 42.2%
CIPLA 6.4% 1.6% -3.1%
DR REDDYS LABORATORIES 6.2% 1.6% 0.2%
MANKIND PHARMA 1.8% 1.8% 6.6%
LUPIN -0.4% 3.5% 22.5%
ZYDUS LIFESCIENCES 2.9% 2.1% 15.7%

CONCORD DRUGS Quarterly Revenues

Revenues
Q-o-Q

123.11 %

Y-o-Y

264.52 %

Quarters Revenues % Change
Mar2026 ₹38 Cr
123.11
Dec2025 ₹17 Cr
65.28
Sep2025 ₹10 Cr
-24.46
Jun2025 ₹14 Cr
30.86
Mar2025 ₹10 Cr
-3.72
Dec2024 ₹11 Cr
-12.71
Sep2024 ₹12 Cr
5.80
Jun2024 ₹12 Cr -

CONCORD DRUGS Quarterly Operating Profit

Operating Profit
Q-o-Q

58.64 %

Y-o-Y

42.75 %

Quarters Operating Profit % Change
Mar2026 ₹1 Cr
58.64
Dec2025 ₹1 Cr
-14.04
Sep2025 ₹1 Cr
7.97
Jun2025 ₹1 Cr
-3.05
Mar2025 ₹1 Cr
-24.82
Dec2024 ₹1 Cr
59.13
Sep2024 ₹1 Cr
5.29
Jun2024 ₹1 Cr -
Operating Margins
Q-o-Q

-28.83 %

Y-o-Y

-60.81 %

Quarters Operating Margin% % Change
Mar2026 3.95%
-28.83
Dec2025 5.55%
-47.99
Sep2025 10.67%
42.84
Jun2025 7.47%
-25.89
Mar2025 10.08%
-21.92
Dec2024 12.91%
82.34
Sep2024 7.08%
-0.56
Jun2024 7.12% -

CONCORD DRUGS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

141.74 %

Y-o-Y

1,217.50 %

Quarters Profit After Tax % Change
Mar2026 ₹1 Cr
141.74
Dec2025 ₹0 Cr
14.14
Sep2025 ₹0 Cr
63.25
Jun2025 ₹0 Cr
192.50
Mar2025 ₹0 Cr
-82.38
Dec2024 ₹0 Cr
427.91
Sep2024 ₹0 Cr
65.38
Jun2024 ₹0 Cr -
PAT Margins
Q-o-Q

8.59 %

Y-o-Y

265.79 %

Quarters PAT Margin(%) % Change
Mar2026 1.39 %
8.59
Dec2025 1.28 %
-31.18
Sep2025 1.86 %
116.28
Jun2025 0.86 %
126.32
Mar2025 0.38 %
-81.90
Dec2024 2.1 %
500.00
Sep2024 0.35 %
59.09
Jun2024 0.22 % -

CONCORD DRUGS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

150.00 %

Y-o-Y

900.00 %

Quarters EPS % Change
Mar2026 ₹0.4
150.00
Dec2025 ₹0.16
-15.79
Sep2025 ₹0.19
58.33
Jun2025 ₹0.12
200.00
Mar2025 ₹0.04
-82.61
Dec2024 ₹0.23
475.00
Sep2024 ₹0.04
33.33
Jun2024 ₹0.03 -

You may also like the below Video Courses